This study aims to find out if a dietary supplement called *citicoline* can help with *sleep and cognition* (thinking and memory). It focuses on people with mild cognitive impairment (MCI), a condition where people have trouble remembering things or thinking clearly. Researchers want to see if citicoline can improve these problems and also look at certain *biomarkers* (markers in the body that show if a disease like Alzheimer's is present).
The study is a randomized double-blind placebo-controlled pilot trial. This means participants are randomly assigned to receive either citicoline or a placebo (a harmless pill with no medicine). Neither the participants nor the researchers know who is taking the real supplement. This helps ensure fair results.
- Participation Length: Participants must be willing to complete several visits and assessments.
- Eligibility: Must be 60 or older with MCI and meet other health criteria.
- Compensation: Participants may receive some form of compensation for their time and involvement.